NKTR-181 BID tablets
14-181-08
Phase 3 small_molecule completed
Quick answer
NKTR-181 BID tablets for Low Back Pain is a Phase 3 program (small_molecule) at NEKTAR THERAPEUTICS with 2 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Low Back Pain
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed